Chromosomal translocations in cancer

Biochimica Et Biophysica Acta
Mridula NambiarSathees C Raghavan

Abstract

Genetic alterations in DNA can lead to cancer when it is present in proto-oncogenes, tumor suppressor genes, DNA repair genes etc. Examples of such alterations include deletions, inversions and chromosomal translocations. Among these rearrangements chromosomal translocations are considered as the primary cause for many cancers including lymphoma, leukemia and some solid tumors. Chromosomal translocations in certain cases can result either in the fusion of genes or in bringing genes close to enhancer or promoter elements, hence leading to their altered expression. Moreover, chromosomal translocations are used as diagnostic markers for cancer and its therapeutics. In the first part of this review, we summarize the well-studied chromosomal translocations in cancer. Although the mechanism of formation of most of these translocations is still unclear, in the second part we discuss the recent advances in this area of research.

References

Jan 15, 1976·International Journal of Cancer. Journal International Du Cancer·L ZechG Klein
Jun 1, 1992·The Journal of Experimental Medicine·R T WyattT G Krontiris
Jan 1, 1992·Annual Review of Immunology·S J Korsmeyer
Dec 22, 1989·Cell·D G SchatzD Baltimore
Jul 1, 1989·Genes & Development·J E HesseM Gellert
Apr 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·C Turc-CarelA A Sandberg
Apr 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·A BakhshiS J Korsmeyer
Nov 18, 1983·Science·P LederR Taub
Dec 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·R TaubP Leder
Nov 10, 1994·Nature·T H Rabbitts
Jun 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·W A MayC T Denny
Dec 24, 1996·Proceedings of the National Academy of Sciences of the United States of America·M A WetermanA Geurts van Kessel
Jun 1, 1997·Molecular and Cellular Biology·S M LewisL Czyzyk
Nov 21, 1998·Genes, Chromosomes & Cancer·S R ChagantiR S Chaganti
Jun 25, 1999·Molecular Genetics and Metabolism·P L Deininger, M A Batzer
Jun 3, 2000·Annual Review of Immunology·S D FugmannD G Schatz
Aug 10, 2000·The American Journal of Pathology·B LawrenceJ A Fletcher
Jun 8, 2001·The Journal of Biological Chemistry·S C RaghavanM R Lieber
Oct 19, 2001·Oncogene·R Küppers, R Dalla-Favera
Oct 19, 2001·Oncogene·S E AsplandC Murre
Jan 10, 2002·The Journal of Experimental Medicine·Rodrig MarculescuBertrand Nadel
Mar 9, 2002·Molecular and Cellular Biology·Gregory S LeeDavid B Roth
Mar 21, 2002·Nature Reviews. Cancer·J D Rowley
Mar 28, 2002·Cellular and Molecular Life Sciences : CMLS·B Elliott, M Jasin
Aug 31, 2002·Genes, Chromosomes & Cancer·Elena KolomietzJeremy A Squire

❮ Previous
Next ❯

Citations

Jun 3, 2009·Annals of Hematology·Mridula Nambiar, Sathees C Raghavan
Dec 31, 2010·Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology·Sarah L Thompson, Duane A Compton
Jan 14, 2010·Investigational New Drugs·M S ShahabuddinSathees C Raghavan
Feb 20, 2010·Investigational New Drugs·Kishore K Chiruvella, Sathees C Raghavan
Aug 12, 2010·The Journal of Biological Chemistry·Tadi Satish KumarSathees C Raghavan
Jan 26, 2012·The Journal of Biological Chemistry·Mridula Nambiar, Sathees C Raghavan
Jul 28, 2010·Molecular Biology of the Cell·Justin HaworthAnja-Katrin Bielinsky
Apr 19, 2011·Nucleic Acids Research·Mridula Nambiar, Sathees C Raghavan
May 17, 2012·Genome Research·Milana Frenkel-MorgensternAlfonso Valencia
Mar 23, 2011·Biochemistry. Biokhimii︠a︡·E V Chetverina, A B Chetverin
Dec 14, 2012·PLoS Computational Biology·Mikhail ShugayFrancisco J Novo
Apr 30, 2014·Cell Communication and Signaling : CCS·Julia Banzhaf-Strathmann, Dieter Edbauer
Jan 31, 2014·Cellular and Molecular Life Sciences : CMLS·José A MartinaRosa Puertollano
Aug 4, 2010·Cellular and Molecular Life Sciences : CMLS·Sheetal SharmaSathees C Raghavan
Sep 6, 2012·Cellular and Molecular Life Sciences : CMLS·Mridula Nambiar, Sathees C Raghavan
Apr 25, 2013·Medical Hypotheses·Vala KafilYadollah Omidi
Sep 14, 2010·Bioorganic & Medicinal Chemistry Letters·Balaji T MoorthySathees C Raghavan
Sep 26, 2009·Biochemical and Biophysical Research Communications·Tomiteru ToganoRyouichi Horie
Jun 2, 2009·Biochemical Pharmacology·Bharat B AggarwalPrashasnika Gehlot
Jun 8, 2011·International Journal of Cell Biology·Ying Lu, Guo-Qiang Chen
May 21, 2009·Genes, Chromosomes & Cancer·Katrina VanuraBertrand Nadel
Sep 28, 2010·Environmental and Molecular Mutagenesis·Joe ShugaMartyn T Smith
Jul 26, 2012·European Journal of Haematology·Kristiane Hornung HamborgCharlotte Guldborg Nyvold
Jan 18, 2012·Genes, Chromosomes & Cancer·Eva FalckKarin Klinga-Levan
Nov 19, 2008·Biochemical Pharmacology·C V KavithaSathees C Raghavan
Sep 19, 2015·Database : the Journal of Biological Databases and Curation·Praveen Kumar KorlaKa-Lok Ng
Apr 29, 2015·The FEBS Journal·Saniya M Javadekar, Sathees C Raghavan
Mar 29, 2013·European Journal of Medicinal Chemistry·H D GurupadaswamyShaukath Ara Khanum
May 2, 2009·Biochimica Et Biophysica Acta·Michael A Tainsky
Feb 7, 2012·Journal of Molecular Biology·Kishore K ChiruvellaSathees C Raghavan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinosarcoma

Carcinosarcoma is a malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. Discover the latest research on carcinosarcoma here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis